From Wikipedia, the free encyclopedia

	Lamivudine is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start	This article has been rated as start-Class on the quality scale.
High	This article has been rated as high-importance for this Project's importance scale.

Contents 1 Patent expiry 2 NPOV issue? 2.1 structure stereochemistry 2.2 minor edit

[edit] Patent expiry

According to GSK's annual report, the patent expires 2010 in US and 2011 in Europe. Unless anyone can find a source for the 2016 date in the article, I'll change it. 203.214.62.109 15:04, 2 June 2007 (UTC)

[edit] NPOV issue?

"GlaxoSmithKline sought to perpetuate the fiction that..." seems rather polemic in tone. Need to look into the history of that edit. Ccreitz 18:50, 5 June 2007 (UTC)

[edit] structure stereochemistry

appears incorrect to me, the base and 5'CH2OH should be on the same side of the ring 155.91.28.231 13:18, 12 September 2007 (UTC)

I've uploaded a new structure. Thank you for bringing this up. Fvasconcellos (t·c) 13:43, 12 September 2007 (UTC)

I'm afraid it's still incorrect. The current picture has D-stereochemistry, while lamivudine has the nonnatural L-stereochemistry. —Preceding unsigned comment added by 155.91.28.231 (talk) 18:16, 12 September 2007 (UTC)

Got it. Fvasconcellos (t·c) 19:43, 12 September 2007 (UTC)

[edit] minor edit

"Physical Interaction with Tenofovir DF" was showing up with funny lines i just edited it without changing any content. —Preceding unsigned comment added by 82.44.253.212 (talk) 04:37, 24 February 2008 (UTC)